LEXARIA BIOSCIENCE CORP. Convertible Debt, Noncurrent
LEXARIA BIOSCIENCE CORP. (LEXX) had Convertible Debt, Noncurrent of $0 as of 2017-08-31, per its 10-K filed 2017-11-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2017-11-27
- 2017-08-31: Convertible Debt, Noncurrent $0.00.
- 2017-05-31: Convertible Debt, Noncurrent $45.00K.
- 2017-02-28: Convertible Debt, Noncurrent $45.00K.
- 2016-11-30: Convertible Debt, Noncurrent $45.00K.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2017-08-31 | $0.00 10-K · filed 2017-11-27 |
| 2017-05-31 | $45.00K 10-Q · filed 2017-07-14 |
| 2017-02-28 | $45.00K 10-Q · filed 2017-04-14 |
| 2016-11-30 | $45.00K 10-Q · filed 2017-01-13 |
| 2016-08-31 | $45.00K 10-K · filed 2017-11-27 |
| 2016-05-31 | $45.00K 10-Q · filed 2016-07-13 |
| 2015-08-31 | $0.00 10-K · filed 2016-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |